Teza Capital Management’s Elevance Health ELV Stock Holding History

Teza Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,320	Closed	-$574K	–	366
2025 Q1	$574K	Buy	+1,320	New	+$530K	0.26%	127
2023 Q3	–	Sell	-2,366	Closed	-$1.05M	–	635
2023 Q2	$1.05M	Buy	2,366 +1,318	+126%	+$608K	0.17%	169
2023 Q1	$482K	Sell	1,048 -681	-39%	-$324K	0.1%	280
2022 Q4	$887K	Buy	1,729 +737	+74%	+$374K	0.17%	197
2022 Q3	$451K	Sell	992 -473	-32%	-$226K	0.09%	312
2022 Q2	$707K	Buy	+1,465	New	+$725K	0.27%	124
2021 Q3	–	Sell	-3,156	Closed	-$1.21M	–	412
2021 Q2	$1.21M	Buy	+3,156	New	+$1.21M	0.2%	147
2020 Q3	–	Sell	-9,013	Closed	-$2.37M	–	444
2020 Q2	$2.37M	Buy	+9,013	New	+$2.4M	0.52%	35
2019 Q4	–	Sell	-5,276	Closed	-$1.27M	–	605
2019 Q3	$1.27M	Buy	+5,276	New	+$1.45M	0.32%	92
2019 Q2	–	Sell	-3,885	Closed	-$1.11M	–	374
2019 Q1	$1.11M	Buy	+3,885	New	+$1.12M	0.59%	39
2018 Q2	–	Sell	-4,873	Closed	-$1.07M	–	491
2018 Q1	$1.07M	Buy	+4,873	New	+$1.14M	0.26%	116
2017 Q2	–	Sell	-8,148	Closed	-$1.35M	–	127
2017 Q1	$1.35M	Buy	+8,148	New	+$1.3M	0.39%	68

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Teza Capital Management's ELV Position: Q2 2025 in Review

Teza Capital Management sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 1,320 shares — an estimated $574K sold.

Teza Capital Management first reported a position in ELV in Q1 2017 and held it in 12 quarters. The position peaked at $2.37M in Q2 2020. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

Teza Capital Management reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
Teza Capital Management sold 1,320 Elevance Health shares in Q2 2025, an estimated $574K.
Teza Capital Management first reported a position in Elevance Health in Q1 2017 and held it in 12 quarters.
Teza Capital Management's Elevance Health position peaked at $2.37M in Q2 2020.
1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Teza Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.